asparaginase - CISMeF

Preferred Label : asparaginase;

MeSH definition : A hydrolase enzyme that converts L-asparagine and water to L-aspartate and NH3. EC 3.5.1.1.;

MeSH synonym : colaspase; asparaginase ii; asparagine deaminase; deaminase, asparagine;

CISMeF synonym : Rhône-Poulenc rorer brand of asparaginase; asparaginase bayer brand; asparaginase bellon brand; asparaginase christiaens brand; asparaginase ispen brand; asparaginase medac brand; asparaginase merck brand; asparaginase sanfer brand; asparaginase speywood brand; bayer brand of asparaginase; bellon brand of asparaginase; christiaens brand of asparaginase; ispen brand of asparaginase; medac brand of asparaginase; merck brand of asparaginase; rhône poulenc rorer brand of asparaginase; sanfer brand of asparaginase; speywood brand of asparaginase;

MeSH hyponym : crasnitin; erwinase; elspar; paronal; kidrolase; asparaginase medac; Leunase; medac, Asparaginase;

MeSH CAS label : L-Asparagine amidohydrolase;

Registry Number MeSH : EC 3.5.1.1;

Wikipedia link : https://en.wikipedia.org/wiki/Asparaginase;

Is substance : O;

UNII : EC 3.5.1.1;

Details

Origin ID

D001215;

UMLS CUI

C0003993;

ATC code(s)
- asparaginase [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Asparaginase [ICD-11 Extension code]
- Asparaginase [Substance BNPC]
- Asparaginase [NCIt concept]
- Asparaginase (substance) [SNOMED CT concept]
- Colaspase [ICD-11 Extension code]
- asparaginase [SNOMED Notion]
Pharmacological action(s)
- antineoplastic agents [MeSH Descriptor]
Record concept(s)
- asparaginase [MeSH concept]
- asparaginase medac [MeSH concept]
- crasnitin [MeSH concept]
- elspar [MeSH concept]
- erwinase [MeSH concept]
- kidrolase [MeSH concept]
- paronal [MeSH concept]
Related MeSH Supplementary Concept(s)
- ABLE protocol [MeSH Supplementary Concept]
- ACOPA II protocol [MeSH Supplementary Concept]
- ADA protocol [MeSH Supplementary Concept]
- AIEOP 8703 protocol [MeSH Supplementary Concept]
- AIEOP acute lymphoblastic leukemia protocol [MeSH Supplementary Concept]
- AIEOP protocol 8202 [MeSH Supplementary Concept]
- AL851 protocol [MeSH Supplementary Concept]
- ALHR88 protocol [MeSH Supplementary Concept]
- ALL-1 protocol [MeSH Supplementary Concept]
- ALL-BFM-95 protocol [MeSH Supplementary Concept]
- ALL-VI protocol [MeSH Supplementary Concept]
- ASRGL1 protein, human [MeSH Supplementary Concept]
- Asrgl1 protein, rat [MeSH Supplementary Concept]
- BFM-86 protocol [MeSH Supplementary Concept]
- BFM-ALL 81 protocol [MeSH Supplementary Concept]
- Berlin-Frankfurt-Muenster protocol II [MeSH Supplementary Concept]
- CART protocol [MeSH Supplementary Concept]
- CCG-141 protocol [MeSH Supplementary Concept]
- COPAD protocol [MeSH Supplementary Concept]
- DCVP-1-asp protocol [MeSH Supplementary Concept]
- DFCI 85-01 protocol [MeSH Supplementary Concept]
- DFCI 91-01 protocol [MeSH Supplementary Concept]
- DFCI 95-01 protocol [MeSH Supplementary Concept]
- EMLP protocol [MeSH Supplementary Concept]
- FRALLE 93 protocol [MeSH Supplementary Concept]
- GIMEMA LAL 0288 protocol [MeSH Supplementary Concept]
- HEAVD protocol [MeSH Supplementary Concept]
- HR-2 protocol [MeSH Supplementary Concept]
- HR-3 protocol [MeSH Supplementary Concept]
- IVAP protocol [MeSH Supplementary Concept]
- LL-IV-81 protocol [MeSH Supplementary Concept]
- LLA-IV-AR protocol [MeSH Supplementary Concept]
- LOP protocol [MeSH Supplementary Concept]
- LSA(2)L(2) protocol [MeSH Supplementary Concept]
- MAPO protocol [MeSH Supplementary Concept]
- MLL-93 protocol [MeSH Supplementary Concept]
- MOPA-6 protocol [MeSH Supplementary Concept]
- MSK-NY-II protocol, modified [MeSH Supplementary Concept]
- Ntan1 protein, Drosophila [MeSH Supplementary Concept]
- OPAL protocol [MeSH Supplementary Concept]
- PETHEMA ALL-96 protocol [MeSH Supplementary Concept]
- PM-asparaginase [MeSH Supplementary Concept]
- POG 8602 protocol [MeSH Supplementary Concept]
- PVDA protocol [MeSH Supplementary Concept]
- Stanford-NCOG protocol [MeSH Supplementary Concept]
- TGAP protocol [MeSH Supplementary Concept]
- TRAMPCOL protocol [MeSH Supplementary Concept]
- TSOP protocol [MeSH Supplementary Concept]
- UKALL X protocol [MeSH Supplementary Concept]
- VAA protocol [MeSH Supplementary Concept]
- VAMA protocol [MeSH Supplementary Concept]
- VCAA protocol [MeSH Supplementary Concept]
- VEPA-L protocol [MeSH Supplementary Concept]
- VPDA protocol [MeSH Supplementary Concept]
- asrgl1 protein, mouse [MeSH Supplementary Concept]
- calaspargase pegol [MeSH Supplementary Concept]
- eryaspase [MeSH Supplementary Concept]
- monomethoxypolyethylene glycol-conjugated asparaginase [MeSH Supplementary Concept]
- new york protocol [MeSH Supplementary Concept]
- non-Hodgkin's lymphoma protocol 8503 [MeSH Supplementary Concept]
- palmitoyl-L-asparaginase [MeSH Supplementary Concept]
- pegaspargase [MeSH Supplementary Concept]
- polyethylene glycol-glutaminase-asparaginase [MeSH Supplementary Concept]
- protocol 8001 [MeSH Supplementary Concept]
- stanford university protocol [MeSH Supplementary Concept]
- succinylated glutaminase-asparaginase [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Enzyme [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Asparaginase [Substance BNPC]
- Asparaginase [ICD-11 Extension code]
- Asparaginase [NCIt concept]
- Asparaginase (substance) [SNOMED CT concept]
- Product containing asparaginase (medicinal product) [SNOMED CT concept]
- asparaginase [ATC Code]
- asparaginase [SNOMED Notion]
- l-asparaginase preparation [SNOMED Notion]
Validated automatic mappings to BTNT
- asparaginase [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients